Ventricular Tachycardia in Structural Heart Disease: A Registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This nationwide, multicenter registry enrolls about 1,000 adults with documented sustained VT or clinically treated nonsustained VT in the context of structural heart disease. It collects detailed clinical data, imaging, electrophysiology findings, treatments, and long-term outcomes to describe real-world patterns and prognostic factors. The study uses standard clinical care without additional interventions beyond routine management. Participants are followed prospectively to observe outcomes and determine factors associated with prognosis in SHD-VT.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged ≥18 years.
* Documented sustained ventricular tachycardia (VT), or nonsustained VT requiring therapeutic intervention in the investigator's judgment, confirmed by a 12-lead electrocardiogram, ambulatory electrocardiographic monitoring, continuous cardiac monitoring, implantable cardiac device recordings, or electrophysiological study.
* Structural heart disease diagnosed according to current clinical guidelines.
* Willing and able to provide written informed consent.
* Willing to comply with the study follow-up schedule.

Exclusion Criteria:

* Ventricular tachycardia secondary to reversible causes (e.g., acute myocardial ischemia or electrolyte disturbances).
* Idiopathic ventricular tachycardia without evidence of structural heart disease.
* Cardiac surgery within 60 days before enrollment.
* Severe infectious diseases (e.g., septic shock or sepsis).
* Severe coagulation disorders, including platelet count \<50 × 10⁹/L or disseminated intravascular coagulation.
* Participation in another interventional clinical study that may interfere with this registry.
* Any other condition that, in the investigator's judgment, makes the participant unsuitable for study participation.

Where it's running

• Beijing Anzhen Hospital, Capital Medical University
  Beijing, China Recruiting

Study contacts

• Principal investigator: Deyong Long — Beijing Anzhen Hospital
• Study coordinator: Deyong Long, MD
• Email: dragon2008@vip.sina.com
• Phone: +86 (010) 84005361

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk of malignant arrhythmias after acute coronary syndrome

  This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07824050

• Targeted ablation to block scar channels that cause ventricular tachycardia

  This study tests whether targeted radiofrequency ablation of scar-channel exits can prevent ventricular tachycardia in patients with scarred hearts.

  Recruiting New York Medical College · Valhalla, New York · NCT07814079

• Predict Arrhythmia Risk with Intelligent Software

  Researchers are testing AI-powered predictions to see if clinicians can spot patients at risk for dangerous heart rhythms using bedside ECG data.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07792694

• Severe Complications During VT/PVC Ablation

  This study looks at real-world cases to see what severe complications occur during VT or PVC ablations and how patients are managed afterward.

  Recruiting at 25 sites University Hospital, Basel, Switzerland · Chicago, Illinois and 24 other locations · NCT07777744

• Non-invasive mapping to help treat ventricular tachycardia due to heart disease

  This study tests a non-invasive mapping tool to guide VT ablation in adults with structural heart disease and prior heart attack.

  Recruiting at 2 sites University of Warwick · Brighton and 2 other locations · NCT07759427

• Personalised VT substrate mapping with dynamic voltage mapping during ablation

  A procedure study to see if using dynamic voltage mapping during VT ablation helps identify and treat scar-related electrical circuits in people with ventricular tachycardia.

  Recruiting Liverpool Heart and Chest Hospital NHS Foundation Trust · Liverpool · NCT07573579

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.